BANGALORE (Reuters) - As the credit crunch worsens, more small drugmakers are resorting to desperate measures like cutting jobs and halting trials of less-important drugs to save up cash for development of their lead products. Pharmaceutical [Continue ]
November 8, 2008
Small drug developers cut jobs to save cash in crunch - Reuters India
« Glucosamine and/or Chondroitin no better than placebo in slowing - Xagena Medical News
Healthcare tourism becoming a reality as Dubai attracts international - Mena Report »
No Comments
No comments yet.
RSS feed for comments on this post.
Sorry, the comment form is closed at this time.